196 related articles for article (PubMed ID: 26919245)
1. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma.
Chen RH; Du Y; Han P; Wang HB; Liang FY; Feng GK; Zhou AJ; Cai MY; Zhong Q; Zeng MS; Huang XM
Oncotarget; 2016 Mar; 7(13):16910-22. PubMed ID: 26919245
[TBL] [Abstract][Full Text] [Related]
2. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
[TBL] [Abstract][Full Text] [Related]
3. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
4. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
5. The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis.
Liu TH; Zheng F; Cai MY; Guo L; Lin HX; Chen JW; Liao YJ; Kung HF; Zeng YX; Xie D
Oncotarget; 2016 May; 7(18):25836-48. PubMed ID: 27028992
[TBL] [Abstract][Full Text] [Related]
6. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
7. A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma.
Jiang Q; Zhou Y; Yang H; Li L; Deng X; Cheng C; Xie Y; Luo X; Fang W; Liu Z
Oncotarget; 2016 Oct; 7(41):67288-67301. PubMed ID: 27589832
[TBL] [Abstract][Full Text] [Related]
8. LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.
Gao L; Cheng XL; Cao H
Biochimie; 2018 Sep; 152():63-72. PubMed ID: 29959065
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma.
Lian YF; Yuan J; Cui Q; Feng QS; Xu M; Bei JX; Zeng YX; Feng L
PLoS One; 2016; 11(3):e0152820. PubMed ID: 27030985
[TBL] [Abstract][Full Text] [Related]
10. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
[TBL] [Abstract][Full Text] [Related]
11. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
[TBL] [Abstract][Full Text] [Related]
12. ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell-like features in cisplatin-resistant ovarian cancer.
Zhang Q; Wang J; Qiao H; Huyan L; Liu B; Li C; Jiang J; Zhao F; Wang H; Yan J
J Cell Mol Med; 2021 May; 25(9):4395-4407. PubMed ID: 33797839
[TBL] [Abstract][Full Text] [Related]
13. High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma.
Shi C; Guan Y; Zeng L; Liu G; Zhu Y; Xu H; Lu Y; Liu J; Guo J; Feng X; Zhao X; Jiang W; Li G; Li G; Dai Y; Jin F; Li W; Zhou W
Int J Oncol; 2018 Sep; 53(3):1138-1148. PubMed ID: 29956730
[TBL] [Abstract][Full Text] [Related]
14. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
Xie P; Yang JP; Cao Y; Peng LX; Zheng LS; Sun R; Meng DF; Wang MY; Mei Y; Qiang YY; Cao L; Xiang YQ; Luo DH; Yun JP; Huang BJ; Jia LJ; Qian CN
Cell Death Dis; 2017 Jun; 8(6):e2834. PubMed ID: 28569775
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells.
Xu X; Liu Y; Su J; Li D; Hu J; Huang Q; Lu M; Liu X; Ren J; Chen W; Sun L
Oncol Rep; 2016 Feb; 35(2):923-31. PubMed ID: 26573774
[TBL] [Abstract][Full Text] [Related]
16. Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell.
Peng S; Wu C; Sun W; Liu D; Luo M; Su B; Zhang L; Mei Q; Hu G
Head Neck; 2018 Mar; 40(3):485-497. PubMed ID: 29024225
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of prostate stem cell antigen (PSCA) by Slug promotes metastasis in nasopharyngeal carcinoma.
Wang L; Sang Y; Tang J; Zhang RH; Luo D; Chen M; Deng WG; Kang T
J Pathol; 2015 Dec; 237(4):411-22. PubMed ID: 26147638
[TBL] [Abstract][Full Text] [Related]
18. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
19. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.
Qin L; Yin YT; Zheng FJ; Peng LX; Yang CF; Bao YN; Liang YY; Li XJ; Xiang YQ; Sun R; Li AH; Zou RH; Pei XQ; Huang BJ; Kang TB; Liao DF; Zeng YX; Williams BO; Qian CN
Oncotarget; 2015 Apr; 6(12):10239-52. PubMed ID: 25823923
[TBL] [Abstract][Full Text] [Related]
20. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]